A more recent meta-analysis including over 11,000 patients receiving PD-1 inhibitors specifically found the pooled incidence of AKI (defined as serum creatinine at least increase >0.3 mg/dL or creatinine at least >1.5–2 times above baseline) to be 2% (22). The gene discussed is PDCD1; the disease is acute kidney injury.